Public preview. Funding rounds, founders, and growth signals require a free account.
Unlock full profile
Metavention, Inc.
Metavention develops a minimally invasive renal denervation system that uses radio frequency energy to permanently disrupt overactive sympathetic nerves in order to treat high blood pressure and metabolic diseases. The company is conducting clinical studies to evaluate the safety and efficacy of its iRF Denervation System.
Series BHealthEden Prairie, MN1-10 employees
Total raised
$30.0M
Last round
Equity
$30.0M · Dec 2017
Stage
Series B
Status
Active
Founders & team
Growth signals
Track Metavention, Inc. on FlareSight
Get notified the moment Metavention, Inc. files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.